NCT02602769Recruiting
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
Source: ClinicalTrials.gov · Last updated 21 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Rapid onset Obesity, Hypoventilation, Hypothalamic dysfunction and Autonomic Dysregulation (ROHHAD) is a syndrome named in 2007. The hallmark of the syndrome is the rapid onset obesity and dysregulation of central ventilation. There is little information about the metabolic changes that lead to the rapid onset obesity in these children. The investigators would like to study the metabolic phenotype of these children to understand the disturbances in energy balance that lead to the rapid onset obesity.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 12 (estimated)
- First submitted
- 7 Nov 2015
- Start date
- Nov 2015
- Primary completion date
- Dec 2026
- Lead sponsor
- Columbia University
- Diseases
- Obesity
- NCT number
- NCT02602769
What you commit to
- Study type: Observational
- Planned participants: 12
- From Nov 2015 to the primary completion date, Dec 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Children with known genetic causes of obesity
Who the study is looking for
- Children with ROHHAD syndrome
Age in the registry: 2 years to 20 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Boston Children's Hospital Coordinator of this site? Confirm its status | Boston | United States | Completed |
| Columbia University Irving Medical Center Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.